We are proud to announce our participation to the World Orphan Drug Congress (WODC) Europe, which will be held this October in Amsterdam. A booth will be displayed to engage with attendees and raise awareness about our mission among international stakeholders in the rare disease community.
Also, we will have the privilege of hosting two sessions:
A gene therapy approach for ARSACS: insights from preclinical models – presented by Drs. Francesca Maltecca and Daniel Di Ritis
ARSACS : Finding Solutions for Rare Disease Patients – Sonia Gobeil, Maxine Monk and Dr. Bart Van de Warrenburg
